[go: up one dir, main page]

MX2018006199A - Antibioticos de amplio espectro macrociclico. - Google Patents

Antibioticos de amplio espectro macrociclico.

Info

Publication number
MX2018006199A
MX2018006199A MX2018006199A MX2018006199A MX2018006199A MX 2018006199 A MX2018006199 A MX 2018006199A MX 2018006199 A MX2018006199 A MX 2018006199A MX 2018006199 A MX2018006199 A MX 2018006199A MX 2018006199 A MX2018006199 A MX 2018006199A
Authority
MX
Mexico
Prior art keywords
broad spectrum
compounds
spectrum antibiotics
macrocyclic
macrocyclic broad
Prior art date
Application number
MX2018006199A
Other languages
English (en)
Other versions
MX387476B (es
Inventor
Bradley Schwarz Jacob
John Crawford James
I Higuchi Robert
Andrew Smith Peter
Yu Zhiyong
Chen Yongsheng
F T Koehler Michael
Curran Roberts Tucker
Paraselli Prasuna
Q Ly Cuong
Hu Huiyong
Original Assignee
Rqx Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rqx Pharmaceuticals Inc filed Critical Rqx Pharmaceuticals Inc
Publication of MX2018006199A publication Critical patent/MX2018006199A/es
Publication of MX387476B publication Critical patent/MX387476B/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D245/00—Heterocyclic compounds containing rings of more than seven members having two nitrogen atoms as the only ring hetero atoms
    • C07D245/04—Heterocyclic compounds containing rings of more than seven members having two nitrogen atoms as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

Se proporcionan aquí compuestos antibacterianos, en los que los compuestos en algunas realizaciones tienen una bioactividad de amplio espectro, los compuestos actúan por inhibición de la peptidasa de señalización de tipo 1 bacteriana (SpsB), una proteína esencial en bacterias. También se proporcionan composiciones farmacéuticas y métodos para el tratamiento que usan los compuestos descritos aquí.
MX2018006199A 2015-11-20 2016-11-21 Antibióticos de amplio espectro macrocíclico. MX387476B (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CNPCT/CN2015/095165 2015-11-20
CNPCT/CN2016/105043 2016-11-08
PCT/CN2016/106597 WO2017084629A1 (en) 2015-11-20 2016-11-21 Macrocyclic broad spectrum antibiotics

Publications (2)

Publication Number Publication Date
MX2018006199A true MX2018006199A (es) 2019-01-10
MX387476B MX387476B (es) 2025-03-18

Family

ID=58231314

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2018006199A MX387476B (es) 2015-11-20 2016-11-21 Antibióticos de amplio espectro macrocíclico.

Country Status (12)

Country Link
US (1) US11072635B2 (es)
EP (1) EP3377474B1 (es)
JP (1) JP6873993B2 (es)
KR (1) KR20180109858A (es)
CN (1) CN109219596B (es)
AU (1) AU2016357926B2 (es)
BR (1) BR112018010267A2 (es)
CA (1) CA3005551A1 (es)
IL (1) IL259429B (es)
MX (1) MX387476B (es)
RU (1) RU2761476C2 (es)
WO (1) WO2017084629A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10501493B2 (en) 2011-05-27 2019-12-10 Rqx Pharmaceuticals, Inc. Broad spectrum antibiotics
WO2015179441A2 (en) 2014-05-20 2015-11-26 Rqx Pharmaceuticals, Inc. Macrocyclic broad spectrum antibiotics
CA3005551A1 (en) 2015-11-20 2017-05-26 Rqx Pharmaceuticals, Inc. Macrocyclic broad spectrum antibiotics
PE20191618A1 (es) * 2017-02-15 2019-11-05 Rqx Pharmaceuticals Inc Antibioticos macrociclicos de amplio espectro
EP3688028A2 (en) * 2017-09-29 2020-08-05 Genentech, Inc. Peptide antibiotic complexes and methods of use thereof
PL3968983T3 (pl) * 2019-05-28 2024-03-18 F. Hoffmann-La Roche Ag Makrocykliczne antybiotyki o szerokim zakresie działania

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3128280A (en) 1959-10-23 1964-04-07 Searle & Co 1-(alkoxylated/halogenated phenyl)-3-pyridylmethylureas
US5204328A (en) 1990-06-26 1993-04-20 Merck & Co., Inc. Peptides having atrial natriuretic factor activity
US6048694A (en) 1995-11-03 2000-04-11 E. I. Du Pont De Nemours And Company Bacterial positive selection vector
EP0932617B1 (en) 1996-10-18 2002-01-16 Vertex Pharmaceuticals Incorporated Inhibitors of serine proteases, particularly hepatitis c virus ns3 protease
EP0895999A1 (en) 1997-08-06 1999-02-10 Pfizer Products Inc. C-4" substituted macrolide antibiotics
GB9902399D0 (en) 1999-02-03 1999-03-24 Smithkline Beecham Plc Compounds
US6660832B1 (en) 1999-08-20 2003-12-09 Isis Pharmaceuticals, Inc. Macrocyclic compounds and preparation methods thereof
US6951840B2 (en) 2001-08-31 2005-10-04 Eli Lilly And Company Lipoglycopeptide antibiotics
DE10226921A1 (de) 2002-06-17 2003-12-24 Bayer Ag Antibakterielle Amid-Makrozyklen
NZ544750A (en) 2003-07-17 2009-06-26 Migenix Inc Compositions of amphomycin or aspartocin based lipopeptide antibiotic derivatives and methods of use thereof
DE10358824A1 (de) 2003-12-16 2005-07-21 Bayer Healthcare Ag Antibakterielle Makrozyklen mit substituiertem Biphenyl
DE102005014247A1 (de) 2005-03-30 2006-10-05 Aicuris Gmbh & Co. Kg Antibakterielle Amid-Makrozyklen VI
DE102005014245A1 (de) 2005-03-30 2006-10-05 Aicuris Gmbh & Co. Kg Antibakterielle Amid-Makrozyklen V
CA2791680A1 (en) 2010-03-01 2011-09-09 Myrexis, Inc. Compounds and therapeutic uses thereof
CN102939095A (zh) * 2010-03-09 2013-02-20 默沙东公司 增强β-内酰胺抗菌药物的活性的桥联脂糖肽类
WO2011120071A1 (en) 2010-04-01 2011-10-06 The University Of Queensland Oxytocin peptide analogues
KR20130105659A (ko) 2010-09-15 2013-09-25 더 스크립스 리서치 인스티튜트 광범위 스펙트럼 항생제 아릴로마이신 유사체
US10501493B2 (en) 2011-05-27 2019-12-10 Rqx Pharmaceuticals, Inc. Broad spectrum antibiotics
WO2012166665A2 (en) 2011-05-27 2012-12-06 Rqx Pharmaceuticals, Inc. Broad spectrum antibiotics
CN103159830B (zh) 2011-12-15 2017-06-20 上海来益生物药物研究开发中心有限责任公司 脂肽类化合物
FR2986154B1 (fr) 2012-01-31 2017-08-04 Pierre Fabre Dermo Cosmetique Nouveau systeme photoprotecteur
KR20140140580A (ko) 2012-03-14 2014-12-09 더 스크립스 리서치 인스티튜트 광범위 항생제 아릴로마이신 유사체
CN103788176A (zh) 2012-10-31 2014-05-14 上海来益生物药物研究开发中心有限责任公司 一种arylomycin类化合物及其制备方法和应用
WO2014081886A1 (en) 2012-11-21 2014-05-30 Rqx Pharmaceuticals, Inc. Macrocyclic broad spectrum antibiotics
WO2015179441A2 (en) * 2014-05-20 2015-11-26 Rqx Pharmaceuticals, Inc. Macrocyclic broad spectrum antibiotics
ITUB20154591A1 (it) 2015-10-12 2017-04-12 Crestoptics S R L Apparato di microscopia confocale e relativo procedimento di acquisizione ed elaborazione di immagini
CA3005551A1 (en) 2015-11-20 2017-05-26 Rqx Pharmaceuticals, Inc. Macrocyclic broad spectrum antibiotics
TWI725075B (zh) 2015-11-20 2021-04-21 美商Ｒｑｘ製藥公司 巨環廣效抗生素
PE20191618A1 (es) 2017-02-15 2019-11-05 Rqx Pharmaceuticals Inc Antibioticos macrociclicos de amplio espectro
AU2018243724B2 (en) 2017-03-27 2022-07-28 F. Hoffmann-La Roche Ag Process for making arylomyin ring analogs
EP3688028A2 (en) 2017-09-29 2020-08-05 Genentech, Inc. Peptide antibiotic complexes and methods of use thereof
PL3968983T3 (pl) 2019-05-28 2024-03-18 F. Hoffmann-La Roche Ag Makrocykliczne antybiotyki o szerokim zakresie działania

Also Published As

Publication number Publication date
WO2017084629A1 (en) 2017-05-26
IL259429A (en) 2018-07-31
JP6873993B2 (ja) 2021-05-19
MX387476B (es) 2025-03-18
US11072635B2 (en) 2021-07-27
AU2016357926A1 (en) 2018-06-14
EP3377474A1 (en) 2018-09-26
RU2018122498A (ru) 2019-12-26
IL259429B (en) 2021-12-01
US20200239519A1 (en) 2020-07-30
CN109219596B (zh) 2022-04-19
EP3377474B1 (en) 2023-08-16
JP2019501123A (ja) 2019-01-17
AU2016357926B2 (en) 2021-05-27
CA3005551A1 (en) 2017-05-26
RU2018122498A3 (es) 2020-02-28
BR112018010267A2 (pt) 2018-11-27
EP3377474C0 (en) 2023-08-16
RU2761476C2 (ru) 2021-12-08
KR20180109858A (ko) 2018-10-08
CN109219596A (zh) 2019-01-15

Similar Documents

Publication Publication Date Title
MX2016015218A (es) Antibioticos macrociclicos de amplio espectro.
MX2018006199A (es) Antibioticos de amplio espectro macrociclico.
CY1121701T1 (el) Οργανικες ενωσεις μονοβακταμης για την αντιμετωπιση βακτηριακων λοιμωξεων
CO2019010001A2 (es) Antibióticos macrociclicos de amplio espectro
BR112015011697A2 (pt) antibióticos macrocíclicos de amplo espectro
CL2013002417A1 (es) Compuestos derivados de fluoropiridinona; composición farmacéutica que los comprende; y su uso en el tratamiento de infecciones bacterianas.
MX386742B (es) Antibióticos de amplio espectro macrocíclico.
MX389771B (es) Compuestos de minociclina para biodefensas.
PH12016501988A1 (en) Antibacterial compounds
CR20210682A (es) Antibióticos macrocíclicos de amplio espectro
PH12018500358A1 (en) Compounds for use in an antibacterial applications
CL2019000857A1 (es) Compuestos heterocíclicos y su uso para prevenir o tratar las infecciones bacterianas.
EA201790156A1 (ru) Азетидинилоксифенилпирролидиновые соединения
CL2017001276A1 (es) Derivados de benzotiazol antibacterianos
MA39955A (fr) Compositions désinfectantes et antimicrobiennes, en particulier pour le domaine vétérinaire
EA201891848A1 (ru) Фармацевтическая композиция для применения в лечении фиброза
MX2015014657A (es) Nuevos agentes antibacterianos de fenicol.
EA202091403A1 (ru) Производные 2-оксо-1-пирролидинилимидазотиадиазола
BR112017022796A2 (pt) composições antibacterianas e métodos
PL425328A1 (pl) Zastosowanie α,β-dihydroksantohumolu
JO3477B1 (ar) مركبات أحادي باكتام عضوية لعلاج العدوى البكتيرية
CL2015001603A1 (es) Nuevos compuestos biciclicos y su uso como agentes antibacterianos e inhibidores de ß-lactamasa.
HK1243653A1 (zh) S-亚硝基硫醇的灭菌方法
HK1241754A1 (en) Pulmonary administration of pyocins for treating bacterial respiratory infections